• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• BL Club
• Smartbuy

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Hyderabad, Sept. 17

Aurobindo Pharma Ltd has received a tentative approval to manufacture and market Abacavir Sulfate tablets (60mg) from the US Food and Drug Administration (USFDA).The tablets can be used in combination with other anti-retrovirals in paediatric patients for the treatment of HIV-1 infection. The Hyderabad-based company had earlier received tentative approvals to the same tablets 300 mg and oral solution in 20 mg/ml.

— Our Bureau

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line